SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-028595
Filing Date
2024-07-22
Accepted
2024-07-19 21:20:10
Documents
14
Period of Report
2024-07-17
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41600
2 ex16-1.htm EX-16.1 4099
  Complete submission text file 0001493152-24-028595.txt   222818

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE immx-20240717.xsd EX-101.SCH 3015
4 XBRL LABEL FILE immx-20240717_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE immx-20240717_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3820
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41159 | Film No.: 241129114
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)